Regeneron Pharmaceuticals Total Assets 2010-2024 | REGN

Regeneron Pharmaceuticals total assets for the quarter ending September 30, 2024 were $36.087B, a 17.71% increase year-over-year.

  • Regeneron Pharmaceuticals total assets for 2023 were $33.08B, a 13.23% increase from 2022.
  • Regeneron Pharmaceuticals total assets for 2022 were $29.215B, a 14.86% increase from 2021.
  • Regeneron Pharmaceuticals total assets for 2021 were $25.435B, a 48.19% increase from 2020.

Regeneron Pharmaceuticals Total Assets 2010-2024 | REGN

  • Regeneron Pharmaceuticals total assets for 2023 were $33.08B, a 13.23% increase from 2022.
  • Regeneron Pharmaceuticals total assets for 2022 were $29.215B, a 14.86% increase from 2021.
  • Regeneron Pharmaceuticals total assets for 2021 were $25.435B, a 48.19% increase from 2020.